Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 66.70
-1.30 (-1.91%)
Apr 17, 2026, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 8.18 billion as of April 17, 2026. Its market cap has decreased by -36.08% in one year.
Market Cap
8.18B
Enterprise Value
6.63B
Revenue
36.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
66.70
Market Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has decreased from 8.87B to 8.18B, a decrease of -7.76%. That is a compound annual growth rate of -0.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 8.18B | -22.53% |
| Dec 31, 2025 | 10.56B | -26.53% |
| Dec 31, 2024 | 14.37B | -31.28% |
| Dec 29, 2023 | 20.91B | -42.13% |
| Dec 30, 2022 | 36.13B | 16.16% |
| Dec 30, 2021 | 31.10B | 17.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 11.56B |
| Tanvex BioPharma | 10.86B |
| Locus Cell | 10.22B |
| PharmaEngine | 8.46B |
| Adimmune | 7.80B |
| TaiGen Biopharmaceuticals Holdings | 7.51B |
| Acepodia | 7.25B |
| Savior Lifetec | 6.18B |